"I think this verdict is a reasonably good verdict under the circumstances", Brafman said.
Shkreli called the prosecution "a witch hunt of epic proportions".
Prosecutors said he kept making terrible stock picks which forced him to cook up schemes to recover millions in losses.
Shkreli's lawyer, Benjamin Brafman, described him as someone who "travels to the beat of a very unique drummer".
"Martin is a splendid young fellow however in some cases his relationship building abilities don't decipher", said Brafman.
Shkreli, as the CEO of Turing Pharmaceuticals, is accused of unapologetically raising the price of anAIDS drug from $13.50 per pill to $750.
US Tests Missile Defense System To 'Stay Ahead' Of Threats
Following Pyongyang's missile launch, South Korea and the United States carried out a round of combined ballistic missile drills. Air Force plane over the Pacific Ocean and intercepted by the system located in Alaska, according to an MDA release.
It's been years since the major pharma companies agreed to participate in the Registry of All Trials, meaning that they'd end the practice of only reporting on trials whose outcomes they were pleased with, leaving about half of all trials unreported-on.
"Rarely has a white-collar criminal defendant evoked hatred and scorn from public in the way Shkreli has".
"It allows for a sentence that doesn't even have to include a period of incarceration and if it does, to be honest with you, a much, much lower period of incarceration than the government ever contemplated", he said. As his attorneys argued his case, he squirmed in his seat and sometimes appeared bored. The Associated Press, the Washington Post and the New York Times have stories. "It's that there's something wrong with Martin Shkreli". Despite the fact that the trial had nothing to do with the medication value debate, legal counselors needed to address 300 potential legal hearers more than three days before they could situate a board. To the wealthy elite he courted, Shkreli was a savvy if eccentric Wall Street insider. Specifically, prosecutors painted Shkreli as a scammer and habitual liar. Instead, the broker was forced to cover Shkreli's position and took on losses of more than $7 million. They were caught after one sold weaponry to an undercover agent, prosecutors said. His crime was lying to attract investment in his hedge fund MSMB Capital Management. Prosecutors charged that he then illegally used a pharmaceutical company he founded, Retrophin, to repay the defrauded MSMB investors.
"Shkreli misled investors in his self-indulgent scheme", FBI Assistant Director-in-Charge William F. Sweeney, Jr. said in a statement. "Today's conviction shows that those who corrupt the market will ultimately be brought to justice". When he made bad trades and lost money put into MSMB, he simply attracted more investors by claiming to be making money. "Shkreli's lack of contrition and the way he cut people to the bone with his words no doubt evinced anger in the jurors that Shkreli's defense team simply could not overcome", he said.
Retrophin ousted Shrekli as CEO in 2014 and filed a $65 million lawsuit in 2015 claiming violation of securities rules.
While it's clear prospective jurors, witnesses, and everyone else agrees that there's something wrong with Shkreli that repeatedly punching him in the face may or may not resolve, Shkreli is probably headed to prison.
A sentencing date has not been established, but court watchers expect it to occur within a month. "We fought back, and we feel like we've won".
After agreeing to continue Shkreli's $5 million bail, the judge told him: "I wish you well, Mr. Shkreli".